These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6607208)

  • 1. The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
    Ramos OF; Masucci MG; Bejarano MT; Klein E
    Immunobiology; 1983 Dec; 165(5):403-14. PubMed ID: 6607208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
    Ramos OF; Masucci MG; Klein E
    Cancer Res; 1984 May; 44(5):1857-62. PubMed ID: 6201264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
    Masucci MG; Torsteinsdottir S; Pear W; Carstensen A; Klein E
    J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
    Ramos OF; Masucci MG; Klein E
    Cell Immunol; 1985 Mar; 91(1):178-92. PubMed ID: 3871663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive activity of 12-O-tetradecanoyl phorbol-13-acetate on the induction of cytotoxic T cells in vitro.
    Yamashita U
    Jpn J Cancer Res; 1985 Jul; 76(7):618-25. PubMed ID: 3928558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
    Argov S; Hebdon M; Cuatrecasas P; Koren HS
    J Immunol; 1985 Apr; 134(4):2215-22. PubMed ID: 3855930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol esters inactivate the lytic apparatus of cytotoxic T lymphocytes.
    Russell JH
    J Immunol; 1984 Aug; 133(2):907-12. PubMed ID: 6610713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers.
    Haskard D; Cavender D; Ziff M
    J Immunol; 1986 Sep; 137(5):1429-34. PubMed ID: 3091681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol-ester stimulated lysis of weak and nonspecific target cells by cytotoxic T lymphocytes.
    Russell JH
    J Immunol; 1986 Jan; 136(1):23-7. PubMed ID: 2415619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol 12,13-dibutyrate enhances lateral redistribution of membrane glycoproteins in human blood lymphocytes.
    Patarroyo M; Gahmberg CG
    Eur J Immunol; 1984 Sep; 14(9):781-7. PubMed ID: 6592096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
    Fredrickson GG; Bennett M
    Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
    Kabelitz D; Kunkel HG
    J Immunol; 1983 Jun; 130(6):2505-7. PubMed ID: 6189890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors.
    Truneh A; Albert F; Golstein P; Schmitt-Verhulst AM
    J Immunol; 1985 Oct; 135(4):2262-7. PubMed ID: 2411789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis.
    Orosz CG; Roopenian DC; Bach FH
    J Immunol; 1983 Jun; 130(6):2499-501. PubMed ID: 6602165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
    Edwards MC; Nouri AM; Gordon D; Evans FJ
    Mol Pharmacol; 1983 May; 23(3):703-8. PubMed ID: 6865912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
    Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces the production of lymphocyte-activating factors (LAP) in human lymphocyte cultures.
    Abb J; Deinhardt F
    Arch Geschwulstforsch; 1980; 50(4):327-31. PubMed ID: 6970023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.
    Graves SS; Bramhall J; Bonavida B
    J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.